NCT05860413Completed
Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
To test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 57 (actual)
- First submitted
- 23 Feb 2023
- Start date
- 24 Jan 2023
- Primary completion date
- 20 May 2025
- Lead sponsor
- University of Kansas Medical Center
- Diseases
- Type 2 diabetes
- NCT number
- NCT05860413
What you commit to
- Study type: Interventional
- Participants enrolled: 57
- From 24 Jan 2023 to the primary completion date, 20 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Weight change of \>=5% in the previous 3 months.
- Addition of new antihyperglycemic or weight-reducing medication in the previous 2 months.
- Untreated depression or anxiety, or increase in associated medications in the previous 3 months.
- Pregnancy or lactation within the previous six months
- Currently taking medications that may result in hypoglycemia during fasting and unwilling to stop prior to the study
Other illness
- Serious medical risk such as ongoing treatment for cancer, uncontrolled hypertension, recent cardiac event, or other medical condition presenting acute risk of participation in a lifestyle change program.
Other
- Inability to attend health education meetings.
- Current participation in another lifestyle change intervention, such as a tobacco cessation program or physical activity program.
- Weight of \>450 lbs
Who the study is looking for
- Diagnosed with type 2 diabetes in the past 10 years.
- Age 21-65 years
- BMI of 25 - 45 kg/m2
- HbA1c of 6.7-9.5%, or those with A1c of \<6.7% on glucose-lowering medications
- Ability to participate in a graduated physical activity program
- Clearance from study physician.
Age in the registry: 21 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kansas Medical Center Coordinator of this site? Confirm its status | Kansas City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.